SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Transcend Therapeutics (TSND) -- Ignore unavailable to you. Want to Upgrade?

To: Mike B who wrote (14)3/20/1998 6:43:00 PM
From: Irish  Respond to of 25
 
Mike:
I agree this seems extreme...which is why I was a first time buyer to-day at 2 1/2. Of course only time will tell. Look forward to some posts this week-end who can shine some light on the issues involved here.

Regards Irish



To: Mike B who wrote (14)3/20/1998 7:04:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 25
 
Mike:

Sorry, but I'm not prepared to address the questions that you asked. I had never really considered procysteine for ALS. That is, I wasn't expecting the blindside of all blindsides.

I would like the SEC to look into every share sold on the 11th. I also hope that the Board hauls Gomez' butt out on Monday and fires it.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News